CD79A and neoplasm: This quantitative difference in signaling and its requirement for efficient antibody mediated killing leads to a model where FcαRI signaling is stronger than FcγRIIa signaling in neutrophils, which can explain the efficient killing of IgA-opsonized tumor cells (Figure 5).